Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Metabolism-Centric Overview of the Pathogenesis of Alzheimer's Disease
Somang Kang, Yong‐ho Lee, Jong Eun Lee
Yonsei Medical Journal (2017) Vol. 58, Iss. 3, pp. 479-479
Open Access | Times Cited: 121

Showing 1-25 of 121 citing articles:

Alzheimer’s disease: risk factors and potentially protective measures
Marcos Vinícius Ferreira Silva, Cristina de Mello Gomide Loures, Luan Carlos Vieira Alves, et al.
Journal of Biomedical Science (2019) Vol. 26, Iss. 1
Open Access | Times Cited: 716
A systemic view of Alzheimer disease — insights from amyloid-β metabolism beyond the brain
Jun Wang, Ben J. Gu, Colin L. Masters, et al.
Nature Reviews Neurology (2017) Vol. 13, Iss. 10, pp. 612-623
Closed Access | Times Cited: 709
Alzheimer’s Disease: Treatment Strategies and Their Limitations
Elodie Passeri, Kamil Elkhoury, Margaretha Morsink, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 22, pp. 13954-13954
Open Access | Times Cited: 250
Oxidative stress in biological systems and its relation with pathophysiological functions: the effect of physical activity on cellular redox homeostasis
Joanna Kruk, Hassan Y. Aboul‐Enein, Aleksandra Kładna, et al.
Free Radical Research (2019) Vol. 53, Iss. 5, pp. 497-521
Closed Access | Times Cited: 214
Nutritional patterns associated with the maintenance of neurocognitive functions and the risk of dementia and Alzheimer’s disease: A focus on human studies
Francesca Pistollato, Rubén Calderón Iglesias, Roberto Ruíz, et al.
Pharmacological Research (2018) Vol. 131, pp. 32-43
Closed Access | Times Cited: 196
Blood–Brain Barrier Breakdown: An Emerging Biomarker of Cognitive Impairment in Normal Aging and Dementia
Basharat Hussain, Cheng Fang, Junlei Chang
Frontiers in Neuroscience (2021) Vol. 15
Open Access | Times Cited: 183
Obesity as a Risk Factor for Dementia and Alzheimer’s Disease: The Role of Leptin
Juan Antonio Flores-Cordero, Antonio Pérez‐Pérez, Carlos Jiménez‐Cortegana, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 9, pp. 5202-5202
Open Access | Times Cited: 125
The diabetic brain and cognition
Peter Riederer, Amos D. Korczyn, Sameh S. Ali, et al.
Journal of Neural Transmission (2017) Vol. 124, Iss. 11, pp. 1431-1454
Open Access | Times Cited: 90
Insulin Resistance Exacerbates Alzheimer Disease via Multiple Mechanisms
Zeng-Hui Wei, Jagadish Koya, Sandra E. Reznik
Frontiers in Neuroscience (2021) Vol. 15
Open Access | Times Cited: 60
Significance of Brain Glucose Hypometabolism, Altered Insulin Signal Transduction, and Insulin Resistance in Several Neurological Diseases
Enrique Blázquez, Verónica Hurtado-Carneiro, Yannick Le Baut Ayuso, et al.
Frontiers in Endocrinology (2022) Vol. 13
Open Access | Times Cited: 50
Astrocyte metabolism and signaling pathways in the CNS
Yong-Mei Zhang, Yingbei Qi, Ya-nan Gao, et al.
Frontiers in Neuroscience (2023) Vol. 17
Open Access | Times Cited: 36
Low-dose pioglitazone can ameliorate learning and memory impairment in a mouse model of dementia by increasing LRP1 expression in the hippocampus
Hannah Seok, Minyoung Lee, Eugene Shin, et al.
Scientific Reports (2019) Vol. 9, Iss. 1
Open Access | Times Cited: 75
Increasing cerebral blood flow improves cognition into late stages in Alzheimer’s disease mice
Oliver Bracko, Brendah N. Njiru, Madisen A. Swallow, et al.
Journal of Cerebral Blood Flow & Metabolism (2019) Vol. 40, Iss. 7, pp. 1441-1452
Open Access | Times Cited: 70
Contributions of a high-fat diet to Alzheimer's disease-related decline: A longitudinal behavioural and structural neuroimaging study in mouse models
Colleen Rollins, Daniel Gallino, Vincent Kong, et al.
NeuroImage Clinical (2018) Vol. 21, pp. 101606-101606
Open Access | Times Cited: 66
Insights into Computational Drug Repurposing for Neurodegenerative Disease
Manish Paranjpe, Alice Taubes, Marina Sirota
Trends in Pharmacological Sciences (2019) Vol. 40, Iss. 8, pp. 565-576
Open Access | Times Cited: 66
Midlife Modifiable Risk Factors for Dementia: A Systematic Review and Meta-analysis of 34 Prospective Cohort Studies
M Kellis, Min Zhang, Wei Xu, et al.
Current Alzheimer Research (2020) Vol. 16, Iss. 14, pp. 1254-1268
Closed Access | Times Cited: 64
Epigallocatechin-3-Gallate (EGCG) Improves Cognitive Deficits Aggravated by an Obesogenic Diet Through Modulation of Unfolded Protein Response in APPswe/PS1dE9 Mice
Miren Ettcheto, Amanda Cano, Patrícia Regina Manzine, et al.
Molecular Neurobiology (2019) Vol. 57, Iss. 4, pp. 1814-1827
Closed Access | Times Cited: 60
The Involvement of Peripheral and Brain Insulin Resistance in Late Onset Alzheimer’s Dementia
Jaume Folch, Jordi Olloquequi, Miren Ettcheto, et al.
Frontiers in Aging Neuroscience (2019) Vol. 11
Open Access | Times Cited: 56
The bile acid TUDCA improves glucose metabolism in streptozotocin-induced Alzheimer's disease mice model
Lucas Zangerolamo, Jean Franciesco Vettorazzi, Carina Solon, et al.
Molecular and Cellular Endocrinology (2020) Vol. 521, pp. 111116-111116
Closed Access | Times Cited: 51
Lactobacillus plantarum PS128 prevents cognitive dysfunction in Alzheimer’s disease mice by modulating propionic acid levels, glycogen synthase kinase 3 beta activity, and gliosis
Hei-Jen Huang, Jie-Ling Chen, Jian-Fu Liao, et al.
BMC Complementary Medicine and Therapies (2021) Vol. 21, Iss. 1
Open Access | Times Cited: 43
Inhibition of miR-128 Abates Aβ-Mediated Cytotoxicity by Targeting PPAR-γ via NF-κB Inactivation in Primary Mouse Cortical Neurons and Neuro2a Cells
Lijiao Geng, Tao Zhang, Wei Liu, et al.
Yonsei Medical Journal (2018) Vol. 59, Iss. 9, pp. 1096-1096
Open Access | Times Cited: 58
The Implication of the Brain Insulin Receptor in Late Onset Alzheimer’s Disease Dementia
Jaume Folch, Miren Ettcheto, Oriol Busquets, et al.
Pharmaceuticals (2018) Vol. 11, Iss. 1, pp. 11-11
Open Access | Times Cited: 53
Role of DPP-4 and SGLT2 Inhibitors Connected to Alzheimer Disease in Type 2 Diabetes Mellitus
Adelene Y. L. Sim, Sumit Barua, Jong Youl Kim, et al.
Frontiers in Neuroscience (2021) Vol. 15
Open Access | Times Cited: 40
Abnormal amyloid beta metabolism in systemic abnormalities and Alzheimer’s pathology: Insights and therapeutic approaches from periphery
Rahat Ullah, Tae Ju Park, Xu Huang, et al.
Ageing Research Reviews (2021) Vol. 71, pp. 101451-101451
Open Access | Times Cited: 39
Model-based assessment of mammalian cell metabolic functionalities using omics data
Anne Richelle, Benjamin P. Kellman, Alexander T. Wenzel, et al.
Cell Reports Methods (2021) Vol. 1, Iss. 3, pp. 100040-100040
Open Access | Times Cited: 37
Page 1 - Next Page

Scroll to top